TSX : CPH.TO

Cipher Pharmaceuticals Inc.

$16.4 CAD

-$0.17 (-1.03%)

Volume
9.8K
Average Volume
21.06K
Market Capitalization
$416.42M
P/E Ratio
9.56
Dividend Yield
0.00%
Price Target
Year High
$20.56
Year Low
$11.98
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.25
Company Overview

TSX

Craig J. Mull

Drug Manufacturers - Specialty & Generic

Healthcare

CPH.TO

5

CA

CAD

https://www.cipherpharma.com

19056025840

17253X105

N/A

Liquidity Metrics

0.00

1.25

0.85

0.31

0.00

Sales & Valuation

$51.33M

5.82

2.22

9.88

1.19

Profitability

$1.07

$27.81M

60.82%

39.70%

25.69%

20.19%

P/E Metrics

9.56

0.04

0.04

Analyst Price Target & Rating

Strong Buy

5/5

1 Analysts

%

Financial Health Scores

10.39

6/9

$5.13M

$153.39M

$20.55M

$17.93M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Emilio Presti Director of Sales & Marketing
Ryan Mailling Chief Financial Officer
Shengnan Guo Corporate Controller
Craig J. Mull Interim Chief Executive Officer & Chairman of the Board
Bryan Jacobs President
Poll Results

No votes yet today — be the first to share your view!

About Cipher Pharmaceuticals Inc. (TSX:CPH.TO) Stock

Cipher Pharmaceuticals Inc., founded in 2000 and based in Oakville, Canada, operates as a specialized pharmaceutical enterprise. The company markets a diverse portfolio of commercial therapeutic solutions. These include Epuris (CIP-ISOTRETINOIN), formulated for severe acne; Ozenoxacin, targeting impetigo in both adult and pediatric patients; Actikerall, prescribed for palpable or moderately thick hyperkeratotic actinic keratosis; Vaniqa, a topical cream designed to mitigate unwanted facial hair growth in women; BRINAVESS, utilized for restoring sinus rhythm in adults; and AGGRASTAT, an intravenous anti-platelet medication. Beyond its directly marketed offerings, Cipher's portfolio encompasses various licensed products, such as CIP-Isotretinoin; Lipofen (CIP-Fenofibrate), used in the manage ... ment of hyperlipidemia, a lipid metabolism disorder; and Conzip/Durela (CIP-Tramadol), indicated for the relief of moderate to moderately severe pain. Looking to the future, Cipher maintains a robust developmental pipeline, which includes Trevyent, a vasodilatory prostacyclin analogue aimed at treating pulmonary arterial hypertension; CF-101, under investigation for severe plaque psoriasis and rheumatoid arthritis; MOB-015, a topical terbinafine formulation for onychomycosis; and DTR-001, a novel cream for tattoo removal.

Frequently Asked Questions

What is the current Cipher Pharmaceuticals Inc. (CPH.TO) stock price?

Cipher Pharmaceuticals Inc.(TSX:CPH.TO) stock price is $16.4 in the last trading session. During the trading session, CPH.TO stock reached the peak price of $20.56 while $11.98 was the lowest point it dropped to. The percentage change in CPH.TO stock occurred in the recent session was --1.03% while the dollar amount for the price change in CPH.TO stock was -$0.17.

CPH.TO's industry and sector of operation?

The TSX listed CPH.TO is part of Drug Manufacturers - Specialty & Generic industry that operates in the broader Healthcare sector.

Who are the executives of CPH.TO?

Emilio Presti | Director of Sales & Marketing
Ryan Mailling | Chief Financial Officer
Shengnan Guo | Corporate Controller
Craig J. Mull | Interim Chief Executive Officer & Chairman of the Board
Bryan Jacobs | President

How many employees does CPH.TO have?

Number of CPH.TO employees currently stands at 5. CPH.TO operates from 5750 Explorer Drive, Mississauga, ON L4W 0A9, CA.

Link for CPH.TO official website?

Official Website of CPH.TO is: https://www.cipherpharma.com

How do I contact CPH.TO?

CPH.TO could be contacted at phone #19056025840 and can also be accessed through its website. CPH.TO operates from 5750 Explorer Drive, Mississauga, ON L4W 0A9, CA.

How many shares of CPH.TO are traded daily?

The average number of CPH.TO shares traded daily for last 3 months was 21.06K.

What is the market cap of CPH.TO currently?

The market value of CPH.TO currently stands at $416.42M with its latest stock price at $16.4